Ermias D. Belay, MD, Associate Director for Epidemiologic Science, Division of High-Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease...
Michael Banks, MD, discusses the risk for cirrhosis regression and liver cancer in patients with HCV-related cirrhosis who have already achieved SVR via DAA treatment.
